Newsbenzinga
Reported Earlier, Grace Therapeutics Prices Private Placement Of 4,761,904 Shares At $2.10 Per Share To Fund GTx-104 Manufacturing And Regulatory Work
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…